Syneron stock falls after approval delayed
109512
NEW YORK -- Syneron Medical Ltd. stock fell Tuesday after the US Food and Drug Administration delayed approval of the medical device maker&#39;s cellulite product.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
526924
Momenta announces a delay in the FDA review of its lead drug.
435043
Shares of Synopsys Inc. SNPS.O  tumbled on Wednesday after the semiconductor design software  maker reported lower third-quarter net income and said  fourth-quarter earnings and revenues would be below Wall Street  estimates.
624528
The FASB delays stock option expensing by six months. That's just more time for Big Tech to lobby.
238512
Shares of Pfizer Inc., the world's largest drugmaker, sank Monday on news that the company had halted development of a key new cholesterol treatment that was heralded as its engine for future growth as the company struggles with stagnant sales.
313162
Shares of large drug makers fell on  Thursday after a top U.S. cardiologist questioned the safety of  new arthritis drugs and the performance of U.S. regulators in  monitoring drug safety.
371920
By Linda Loyd, The Philadelphia Inquirer  Dec. 7--Cephalon Inc. shares fell today after the company said U.S. regulators will likely delay final approval of its drug Nuvigil for excessive sleepiness as the agency investigates a case of a serious rash with a related medicine.
222125
Shares of Chiron Corp., the world&#39;s second-biggest seller of influenza vaccines, fell as much as 9.5 percent after saying it would delay shipments of its Fluvirin flu shots until October because of a possible product flaw.
199689
Shares of SuperGen Inc.  dropped 17 percent before the bell on Monday after the company said it withdrew an application to market its pancreatic cancer treatment in the United States due to insufficient data.
407294
The biotech company announces new drug delays.
595967
BOSTON (CBS.MW) -- Shares of embattled vaccine maker Chiron Corp. slipped notably Wednesday after it announced that UK regulatory authorities had extended a suspension on the company&#39;s license to manufacture at its primary flu vaccine-making facility.
114185
Shares drop as U.S. regulators say they want more info before approving caner medication Bonefos.
53495
Shares of Chiron Corp. (CHIR.O) fell 7 percent before the market open on Friday, a day after the biopharmaceutical company said it is delaying shipment of its flu vaccine, Fluvirin, because lots containing 4 million vaccines do not meet product sterility standards.
659659
Despite announcing the biggest news in its short history, OSI Pharmaceuticals stock fell nearly 10 percent Friday, as some investors grew nervous about whether its newly approved cancer drug would be the bonanza they expected.
122895
Drug stocks across the board fell amid renewed safety concerns over a class of blockbuster drugs used to treat arthritis. Preprint articles published on the New England Journal of Medicine&#39;s Web site Wednesday
372356
NEW YORK, November 2  - Forest Laboratories Inc (FRX.NYS) witnessed a decline in its share price this morning, following the news of disappointing efficacy study results for the company&#39;s new hypertension drug.